Your browser is no longer supported. Please, upgrade your browser.
Settings
NVS Novartis AG daily Stock Chart
NVS [NYSE]
Novartis AG
Index- P/E23.87 EPS (ttm)3.39 Insider Own9.30% Shs Outstand2.47B Perf Week6.04%
Market Cap199.68B Forward P/E14.61 EPS next Y5.54 Insider Trans0.33% Shs Float2.47B Perf Month9.27%
Income8.00B PEG3.19 EPS next Q1.28 Inst Own11.40% Short Float0.04% Perf Quarter-0.91%
Sales51.28B P/S3.89 EPS this Y15.20% Inst Trans0.21% Short Ratio0.57 Perf Half Y-6.81%
Book/sh30.57 P/B2.65 EPS next Y6.46% ROA6.00% Target Price88.16 Perf Year-4.49%
Cash/sh2.60 P/C31.09 EPS next 5Y7.48% ROE11.20% 52W Range72.30 - 94.19 Perf YTD-3.57%
Dividend2.98 P/FCF63.72 EPS past 5Y-3.50% ROI7.10% 52W High-14.05% Beta0.82
Dividend %3.68% Quick Ratio0.90 Sales past 5Y-0.70% Gross Margin66.40% 52W Low11.98% ATR1.15
Employees124000 Current Ratio1.20 Sales Q/Q9.70% Oper. Margin17.90% RSI (14)69.35 Volatility0.93% 0.89%
OptionableYes Debt/Eq0.48 EPS Q/Q23.70% Profit Margin15.70% Rel Volume1.70 Prev Close78.70
ShortableYes LT Debt/Eq0.33 EarningsJul 18 BMO Payout78.70% Avg Volume1.79M Price80.96
Recom2.50 SMA206.81% SMA506.46% SMA200-0.98% Volume3,036,336 Change2.87%
May-29-18Downgrade HSBC Securities Buy → Hold
May-25-18Upgrade Credit Suisse Underperform → Neutral
Jan-25-18Reiterated Leerink Partners Outperform $93 → $100
Dec-06-17Downgrade BofA/Merrill Neutral → Underperform
Jul-26-17Upgrade Morgan Stanley Underweight → Overweight
Jul-05-17Downgrade Credit Suisse Neutral → Underperform
Mar-09-17Initiated Liberum Buy
Mar-08-17Upgrade Societe Generale Hold → Buy
Mar-07-17Downgrade Exane BNP Paribas Neutral → Underperform
Jan-11-17Downgrade Credit Suisse Outperform → Neutral
Nov-10-16Upgrade Argus Hold → Buy
Oct-10-16Reiterated Chardan Capital Markets Buy $95 → $92
Sep-20-16Initiated Chardan Capital Markets Buy $95
Apr-12-16Downgrade Morgan Stanley Equal-Weight → Underweight
Mar-23-16Downgrade Leerink Partners Outperform → Mkt Perform
Jun-22-15Upgrade Bryan Garnier Neutral → Buy
Nov-16-09Initiated Deutsche Securities Buy
Nov-12-09Initiated Barclays Capital Underweight $48
Sep-30-09Upgrade Citigroup Hold → Buy
Sep-15-09Upgrade Jefferies & Co Hold → Buy
Jul-18-18 04:27PM  Novartis Q2 Earnings Miss, Sales Top on Cosentyx, Entresto Zacks
03:07PM  5 Big Biotech Stories to Watch TheStreet.com
12:54PM  Novartis hints at 2018 outlook hike despite drug price freeze Reuters
12:32PM  Novartis Earnings: 'A Focused Company Wins,' Says CEO Barrons.com
11:08AM  Novartis AG (NVS) Q2 2018 Earnings Conference Call Transcript Motley Fool
10:50AM  [$$] Novartis Won't Raise U.S. Drug Prices This Year The Wall Street Journal
08:42AM  Benzinga's Daily Biotech Pulse: Novartis Earnings, J&J's HIV Combo Clears FDA Hurdle, Cara To Offer Shares Benzinga
06:53AM  Novartis joins Pfizer in halting U.S. drug price hikes Reuters
05:02AM  Novartis: 2Q Earnings Snapshot Associated Press
04:50AM  Novartis CEO Says It's `Prudent' to Pull Back From Further Price Increases Bloomberg Video
04:50AM  Novartis CEO Says It's `Prudent' to Pull Back From Further Price Increases Bloomberg
04:20AM  Novartis puts brakes on price hikes, bowing to U.S. pressure Reuters
03:16AM  Swiss drugs giant Novartis says profit up as spinoff looms Associated Press
02:36AM  Novartis Joins Pfizer in Holding Line on Drug Prices in U.S. Bloomberg
02:36AM  Novartis CEO Says Drugmaker Won't Raise U.S. Prices This Year Bloomberg
02:11AM  [$$] Novartis Confirms Outlook The Wall Street Journal
01:21AM  Novartis Blockbuster Drug Rebounds, Easing Generics Pressure Bloomberg
Jul-17-18 10:49PM  [$$] Chinese Hit Movie Dying to Survive Injects Urgency in Drug-Price Push The Wall Street Journal
10:13PM  Novartis (NVS) Stock Flat Ahead of Earnings: What To Watch Zacks
04:04PM  Earnings Outlook For Novartis Benzinga
12:33PM  GlaxoSmithKline Is More Than Just a 5% Dividend Income Play InvestorPlace
Jul-16-18 08:15AM  Is a Surprise in the Cards for Novartis in Q2 Earnings? Zacks
08:01AM  The Zacks Analyst Blog Highlights: Johnson & Johnson, Novartis, UnitedHealth and Microsoft Zacks
Jul-13-18 08:04PM  [$$] Novartis Played Down Ties to Trump Lawyer Michael Cohen, Report Says The Wall Street Journal
04:49PM  [$$] Novartis Communicated With Trump's Lawyer for Months, Report Says The Wall Street Journal
03:09PM  Novartis Looks to Exit Antibacterial, Antiviral Program Zacks
01:35PM  Dems: Novartis deal with Cohen sought access to policymakers Associated Press
11:47AM  Novartis Account of Cohen Connection Assailed by U.S. Senators Bloomberg
09:45AM  AT&T failed to provide requested documents to Senate probe of payments made to Michael Cohen MarketWatch
09:21AM  Novartis disputes U.S. senators' report on Cohen contract Reuters
09:16AM  Novartis disputes U.S. senators' report on Cohen contract Reuters
08:43AM  JNJ vs. NVS: Which Stock is Better Pre Q1 Earnings? Zacks
08:36AM  Novartis disputes U.S. senators' report over Cohen contract Reuters
08:33AM  Cohen's Novartis Work Was Broader Than Reported, Democrats Say Bloomberg
08:33AM  Cohen Pitched Novartis Russia-Tied Investment, Democrats Say Bloomberg
08:15AM  Better Know Biotech: Regenxbio Inc. Motley Fool
12:00AM  Superbugs Win Another Round as Big Pharma Leaves Antibiotics Bloomberg
Jul-12-18 09:05PM  [$$] Democrats allege Trump lawyer had broad contacts with Novartis Financial Times
08:59AM  3 Gene Therapy Stocks Investors Can Bet on in Rest of 2018 Zacks
07:15AM  Novartis launches the Galaxies of Hope app, a digital experience for the Neuroendocrine Tumor (NET) cancer community PR Newswire
Jul-11-18 05:53PM  Novartis Exits Antibiotics Research, Cuts 140 Jobs in Bay Area Bloomberg
05:49PM  Once with lofty plans, Novartis now closing East Bay unit, cutting 140 jobs American City Business Journals
01:00PM  Removing the Hidden Obstacle Holding Back New Cancer Therapies Bloomberg
04:47AM  Moody's: European pharma sector earnings poised to rise into 2019 as new drugs come to market Moody's
Jul-10-18 04:47PM  Kate Warne- Investment Strategist Edward Jones Yahoo Finance Video
02:46PM  Drugmakers Cancel Price Hikes After California Law Takes Effect Bloomberg
Jul-09-18 08:58AM  [$$] China vows to accelerate cancer drug price cuts Financial Times
Jul-06-18 09:16AM  Pharma Stock Roundup: NVS to Divest Eye Care Unit, CHMP Gives Nod to Several Drugs Zacks
Jul-05-18 08:47AM  3 Best Biotech Acquisitions of 2018 (So Far) Motley Fool
Jul-03-18 08:41AM  Adamis (ADMP) Surges Following Novartis Deal for Symjepi Zacks
06:51AM  Adamis has a partner to market its EpiPen competitor after a year-long search MarketWatch
Jul-02-18 07:46PM  [$$] Novartis Injects Itself Into Planned Rollout of EpiPen Competitor The Wall Street Journal
05:30PM  [$$] Novartis Injects Itself Into Planned Rollout of EpiPen Rival The Wall Street Journal
03:54PM  Novartis to Spin-Off Alcon as Separate Trading Company Zacks
12:51PM  Novartis Securities Investment Ltd -- Moody's downgrades Novartis' rating to A1; stable outlook Moody's
11:04AM  Adamis Pharma Shares Soar on Deal With Novartis for Epipen Competitor TheStreet.com
10:59AM  Nordstrom may have trouble, Novartis signs distribution deal, Netflix buys LA billboards Yahoo Finance
10:20AM  Nordstrom may have trouble according to analyst, Novartis signs distribution deal for EpiPen competitor, Netflix reportedly buys LA billboards Yahoo Finance Video
Jun-30-18 05:55AM  Novartis chairman says Alcon worth $20 billion-$30 billion: Finanz und Wirtschaft Reuters
05:35AM  Novartis chairman says Alcon worth $20 bln-$30 bln - Finanz und Wirtschaft Reuters
05:35AM  Novartis chairman says Alcon worth $20 billion-$30 billion - Finanz und Wirtschaft Reuters
Jun-29-18 07:29PM  [$$] Novartis to Spin Off Alcon Eye-Care Business The Wall Street Journal
04:52PM  Novartis Surges On Decision To Spin Off Alcon Eye Devices Unit Investor's Business Daily
04:21PM  Stocks Stumble at Friday's Close, Giving Up Most of Day's Gains TheStreet.com
12:44PM  UPDATE 1-Rival Novartis, Gilead CAR-T therapies win European panel recommendation Reuters
12:41PM  Novartis Stock Pops on Alcon Spinoff News InvestorPlace
12:34PM  Nike soars, Novartis jumps, Deutsche Bank on the rise Yahoo Finance
11:30AM  Novartis hands investors Alcon spin-off, $5 billion share buyback Reuters
11:17AM  Nikes stock leaps on earnings report, Novartis spins off Alcon, Fox sets date for Disney vote Yahoo Finance
11:08AM  Novartis hands investors Alcon spin-off, $5 billion share buyback Reuters
11:05AM  Nike, Novartis and Deutsche Bank are the Yahoo Finance charts of the day Yahoo Finance Video
10:34AM  Novartis Is Spinning Off Its Alcon Eye Care Business and Launching a $5 Billion Share Buyback Fortune
10:20AM  Nikes stock leaps on earnings report, Novartis spins off Alcon, Fox sets date for Disney vote Yahoo Finance Video
09:57AM  Interested In Pharmaceutical Stocks? Try Novartis (ADR) Investopedia
09:25AM  Novartis Doesn't Appear Ready to Make Healthy Move Higher TheStreet.com
08:30AM  Ron Squarer's risk-taking pays off at Array American City Business Journals
08:16AM  Rival Novartis, Gilead CAR-T therapies win European panel recommendation Reuters
08:11AM  Benzinga's Daily Biotech Pulse: Gemphire On Fire, Acceleron-Celgene Taste Success, AbbVie Ditches Galapagos Benzinga
08:05AM  Stocks making the biggest moves in the premarket: STZ, WFC, BAC, JPM, C, NKE & more CNBC
07:46AM  Nike, Deutsche Bank, Goldman Sachs and Novartis - 5 Things You Must Know TheStreet.com
07:30AM  Novartis Goes Back to Its $191 Billion Core Bloomberg
07:10AM  Novartis hands investors Alcon spin-off and $5 billion share buyback Reuters
07:02AM  [$$] Novartis to Spin Off Alcon Eye-Care Business The Wall Street Journal
06:40AM  Novartis to Spin Off Eye-Care Unit, Buy Back $5B in Shares Investopedia
06:03AM  [$$] European Stocks Market Talk Roundup The Wall Street Journal
03:43AM  [$$] Novartis Announces Buyback, Eye-Care Spinoff The Wall Street Journal
01:37AM  [$$] Novartis slims down with $25bn spin-off of Alcon eyecare business Financial Times
01:27AM  Novartis to Spin Off Alcon as CEO Focuses on Finding Drugs Bloomberg
Jun-28-18 11:42AM  Piper Jaffray, Stifel Defend Array Biopharma As Stock Falls On Profit-Taking Benzinga
Jun-26-18 07:00AM  Stock Performance Review on Pfizer and Three Other Drug Makers Stocks ACCESSWIRE
05:00AM  [$$] Top lawyers caught in crossfire Financial Times
Jun-24-18 06:32AM  Long-Term Investors Take Note -- These 5 Big Pharma Companies Have the Best Pipelines Motley Fool
Jun-22-18 09:12AM  Incyte (INCY) Announces Positive Results on Jakafi for GVHD Zacks
04:26AM  Looking At Novartis AG (VTX:NOVN) From All Angles Simply Wall St.
Jun-20-18 11:30AM  2 High-Flying Biotech Stocks With Even More Room to Grow Motley Fool
08:00AM  Don't Get Too Excited About PTC Therapeutics (Yet) Motley Fool
Jun-19-18 08:55AM  Zacks Industry Outlook Highlights: H. Lundbeck, Eli Lilly, GlaxoSmithKline and Novartis Zacks
Jun-18-18 10:11AM  Roche SMA drug shines in study as costly new therapies advance Reuters
09:27AM  Novartis Announces Positive Data on CAR-T Therapy, Kymriah Zacks
Jun-15-18 01:09PM  Does Novartis AG (NYSE:NVS) Have A Place In Your Portfolio? Simply Wall St.
Novartis AG researches, develops, manufactures, and markets a range of healthcare products worldwide. The company's Innovative Medicines segment offers patented prescription medicines to enhance health outcomes for patients and health-care providers. This segment also commercializes products in the areas of oncology and rare diseases, ophthalmology, immunology and dermatology, neuroscience, respiratory, cardio-metabolic, and established medicines. The Sandoz segment provides active ingredients and finished dosage forms of pharmaceuticals in the areas of cardiovascular, central nervous system, dermatology, gastrointestinal and hormonal therapies, metabolism, oncology, ophthalmic, pain, and respiratory; active pharmaceutical ingredients and intermediates primarily antibiotics; protein or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. The Alcon segment offers eye care products, such as eye care devices for cataract, retinal, glaucoma, and refractive surgery, as well as intraocular lenses to treat cataracts and refractive errors; viscoelastics, surgical solutions, surgical packs, and other disposable products for cataract and vitreoretinal surgery; and contact lenses, as well as contact lens care products, including multi-purpose and hydrogen-peroxide based solutions, rewetting drops, and daily protein removers. Novartis AG has collaboration agreements with Xencor; Surface Oncology; Intellia Therapeutics; Caribou Biosciences; Bristol-Myers Squibb; IBM Watson Health; Amgen; Allergan plc; Science 37, Inc.; Bill & Melinda Gates Foundation; and PEAR Therapeutics. Novartis AG was founded in 1895 and is headquartered in Basel, Switzerland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Novartis Bioventures Ltd10% OwnerJul 17Sale4.7112,50058,8752,531,382Jul 18 04:17 PM
Novartis Bioventures Ltd10% OwnerJul 16Sale5.153001,5452,543,882Jul 18 04:17 PM
Novartis Institutes for BioMed10% OwnerApr 23Buy15.00766,66611,499,9903,948,482Apr 23 04:43 PM